Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
adjacent, adjuvant, argument, budgetary, chamber, Colorado, COMP, conciliation, daxdilimab, dazodalibep, dermatology, EnspryngTM, headroom, hypothetical, legacy, medium, mentioned, neuroimmunology, plant, quantitative, rescind, stimulate
Removed:
accomplish, adapting, aiding, attempted, campaign, Celebrex, celecoxib, conveying, deficit, dyspepsia, famotidine, gastrointestinal, GI, half, ibuprofen, learn, mitigated, Pfizer, presidential, protective, remotely, repayment, researching, telemedicine, unaware, understand, vigorously, wholesaler
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view